Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biolarvicides in vector control: challenges and prospects.

P K Mittal1

  • 1Malaria Research Centre, 22 Sham Nath Marg, Delhi, India. pk_mittal52@yahoo.co.in

Journal of Vector Borne Diseases
|May 4, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of indoor residual spray and insecticide treated bed nets in a malaria endemic area of Santhal Pargana, Dumka district (Jharkhand).

The Journal of communicable diseases·2014
Same author

Establishment of a focus on Anopheles fluviatilis, an important malaria vector near the National Thermal Power Corporation Project in Dadri CHC area in District Gautam Budh Nagar, Uttar Pradesh, India: a case study.

Journal of vector borne diseases·2014
Same author

Insecticide susceptibility status of Phlebotomus argentipes, a vector of visceral leishmaniasis in different foci in three states of India.

Journal of vector borne diseases·2013
Same author

Field evaluation of Icon®Life, a long-lasting insecticidal net (LLIN) against Anopheles culicifacies and transmission of malaria in District Gautam Budh Nagar (Uttar Pradesh), India.

Journal of vector borne diseases·2012
Same author

Susceptibility of malaria vectors to insecticides in Gadchiroli district (Maharashtra), India.

Journal of vector borne diseases·2012
Same author

Wash resistance and efficacy of Olyset net and Permanet 2.0 against Anopheles stephensi in India.

Journal of the American Mosquito Control Association·2012

Biolarvicides from Bacillus thuringiensis var israelensis H-14 (Bti) offer broad-spectrum mosquito control, while Bacillus sphaericus is effective against specific species but faces resistance issues. Both show potential for integrated mosquito management strategies.

Area of Science:

  • Environmental microbiology
  • Vector control
  • Biotechnology

Background:

  • Biolarvicides derived from Bacillus species are effective and safe mosquito control agents.
  • Extensive testing of various biolarvicide formulations has been conducted over two decades.

Purpose of the Study:

  • To evaluate the efficacy and limitations of Bacillus sphaericus and Bacillus thuringiensis var israelensis H-14 (Bti) biolarvicides.
  • To explore strategies for overcoming challenges in biolarvicide application and resistance development.

Main Methods:

  • Comparative analysis of biolarvicide formulations against different mosquito species.
  • Assessment of large-scale operational trials and field efficacy.
  • Investigation into slow-release formulations and genetic engineering for enhanced biolarvicides.

Related Experiment Videos

Main Results:

  • Bacillus sphaericus is effective against Culex and some Anopheles species but shows limited efficacy against Anopheles culicifacies and Aedes aegypti, with potential for larval resistance.
  • Bacillus thuringiensis var israelensis H-14 (Bti) has broader efficacy but its field performance is impacted by bioenvironmental factors, necessitating frequent application.
  • Development of resistance in target mosquito larvae is a concern for Bacillus sphaericus.

Conclusions:

  • Bacillus sphaericus has limited prospects for malaria vector control due to specificity and resistance, but remains useful for Culex control with resistance management.
  • Bacillus thuringiensis var israelensis H-14 (Bti) formulations offer a promising alternative with broader activity and less resistance development.
  • Future research focuses on slow-release and genetically engineered biolarvicides to improve efficacy and overcome field limitations.